CEXI CDex, Inc. featured news, full reports, and detailed charts
CDex, Inc. (CEXI/CEXI.OB) Wrap Up:
CDEX, Inc., a technology development company, engages in the development and application of chemical detection technologies for products in the healthcare, security, and brand protection markets in the United States and internationally. It offers ValiMed, a medication validation unit, which consists of two solutions comprising ValiMed Impaired Clinician Solution and ValiMed Patient Safety Solution; and CDEX ID2, a handheld, battery operated scanning device that is capable of detecting trace amounts of methamphetamine. The company also engages in the validation of prescription and compounded medications to provide for patient safety, training of medical staff regarding compounding practices, ...www.cdex-inc.com
19 Employees
Founded in 2001
CDex, Inc. (CEXI:OTC Bulletin Board Market)
LAST $0.07 USD
CHANGE TODAY +0.005 7.69%
VOLUME 222.1K
As of 2:40 PM 11/20/09 All times are local (Market data by Reuters is delayed by at least 15 minutes).
Snapshot of CDex, Inc. (CEXI)
|
OPEN
$0.07
|
PREVIOUS CLOSE
$0.07
|
|
|
DAY HIGH
$0.08
|
DAY LOW
$0.07
|
|
|
52 WEEK HIGH
03/16/09 - $0.24
|
52 WEEK LOW
08/18/09 - $0.04
|
|
|
MARKET CAP
4.5M
|
AVERAGE VOLUME 3 mo
68.7K
|
|
|
DILUTED EPS TTM
--
|
SHARES OUTSTANDING
64.2M
|
|
|
CEXI Does Not Pay Dividends
|
P/E TTM
NM
|
|
| K = Thousands M = Millions B = Billions | ||
CEXI Top Compensated Officers
Mr. Malcolm H. Philips Jr.
Chairman, Chief Executive Officer and Preside...
Age: 63
Total Annual Compensation: $231.5K
Mr. Timothy D. Shriver
Chief Operating Officer, Director and Member ...
Age: 58
Total Annual Compensation: $201.8K
Dr. Wade Poteet
Chief Technical Officer and Principal Scienti...
Total Annual Compensation: $138.0K
Mr. August F. DeLuca
Consultant
Age: 65
Total Annual Compensation: $100.8K
Executives, Board Directors
Compensation as of Fiscal Year 2008.
Key developments for CDex, Inc. (CEXI)
CDex Inc. Reports Earnings Results for the Third Quarter Ended July 31, 2009
09/30/2009
CDex Inc. reported earnings results for the third quarter ended July 31, 2009. Net loss for the quarter was $631,834, down from $392,964 for the same quarter the previous year.
CDex, Inc. announced delayed 10-Q filing
09/14/2009
On 09/14/2009, CDex, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
Geisinger Medical Center Proactively Enhances its Medication Safety Program by Selecting the ValiMed(TM) Medication Safety System
09/9/2009
CDEX Inc. announced that Geisinger Medical Center it has selected the ValiMed(TM) Medication Safety System to assure the 'Right Drug at the Right Dose' every time. ValiMed is used to validate accurate compounding of high-risk medications and to reduce the diversion of return narcotics in healthcare facilities.
CEXI Competitors
| Company | Last | Change | |
| No competitor information is available for CEXI. | |||
| Market data is delayed at least 20 minutes. | |||
Industry Analysis
| Valuation | CEXI | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 7.7x |
|
| Price/Book | NM | Not Meaningful |
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | 5.4x |
|
|
CEXI |
||
|
CEXI transactions
| Type Date |
Target | |
| No transactions in the last 6 months. | ||
More Recent News About CDex, Inc.
Would you like to leave a comment about CDex, Inc. CEXI/CEXI.OB
Find out what social network information about CDex, Inc. are available on RealpenniesWorst 5 - Click here to find out what stocks have been voted down by our visitors and users
Besides CDex, Inc. there is more great information available at Realpennies.com